Search Results - Pate, Odeal

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Imatinib Dose Can Be Safely Reduced after Complete Cytogenetic Response (CCyR) in Patients (pts) with Chronic Myeloid Leukemia (CML) in Early Chronic Phase (CP) Treated with High-Dose Imatinib

    Imatinib Dose Can Be Safely Reduced after Complete Cytogenetic Response (CCyR) in Patients (pts) with Chronic Myeloid Leukemia (CML) in Early Chronic Phase (CP) Treated with High-D... by Jain, Nitin, Kantarjian, Hagop M., Fava, Carmen, Thomas, Deborah, Burger, Jan A., Borthakur, Gautam, Pate, Odeal, Cortes, Jorge

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Immune Modulation of Minimal Residual Disease (MRD) in Patients (pts) with Chronic Myelogenous Leukemia (CML) in Early Chronic Phase (CP): A Randomized Trial of Frontline High-Dose (HS) Imatinib Mesylate (IM) with or without Pegylated-Interferon (PEG-IFN) and GM-CSF

    Immune Modulation of Minimal Residual Disease (MRD) in Patients (pts) with Chronic Myelogenous Leukemia (CML) in Early Chronic Phase (CP): A Randomized Trial of Frontline High-Dose... by Quintas-Cardama, Alfonso, Kantarjian, Hagop M., Ravandi, Farhad, Garcia-Manero, Guillermo, O'Brien, Susan, Verstovsek, Srdan, Koller, Charles Asa, Pate, Odeal, Cortes, Jorge

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Phase I Study of Lonafarnib (SCH66336) in Combination with Imatinib for Patients (Pts) with Chronic Myeloid Leukemia (CML) after Failure to Imatinib

    Phase I Study of Lonafarnib (SCH66336) in Combination with Imatinib for Patients (Pts) with Chronic Myeloid Leukemia (CML) after Failure to Imatinib by Cortes, Jorge, O'Brien, Susan, Verstovsek, Srdan, Daley, George, Koller, Charles, Ferrajoli, Alessandra, Pate, Odeal, Faderl, Stefan, Ravandi-Kashani, Farhad, Talpaz, Moshe, Zhu, Yali, Statkevich, Paul, Sugrue, Mary, Kantarjian, Hagop

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Paclitaxel activity for the treatment of non‐Hodgkin's lymphoma: final report of a phase II trial

    Paclitaxel activity for the treatment of non‐Hodgkin's lymphoma: final report of a phase II trial by YOUNES, ANAS, AYOUB, JEAN‐PIERRE, SARRIS, ANDREAS, HAGEMEISTER, FREDERICK, NORTH, LUCILLE, PATE, ODEAL, MCLAUGHLIN, PETER, RODRIGUEZ, M. ALMA, ROMAGUERA, JORGE, KURZROCK, RAZELLE, PRETI, ALEJANDRO, BACHIER, CARLOS, SMITH, TERRY, CABANILLAS, FERNANDO

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Phase I Study of Fludarabine and Paclitaxel for the Treatment of Low-Grade Non-Hodgkin's Lymphoma

    Phase I Study of Fludarabine and Paclitaxel for the Treatment of Low-Grade Non-Hodgkin's Lymphoma by Younes, Anas, Rodriguez, Maria A., McLaughlin, Peter, North, Luceil, Sarris, Andreas H., Pate, Odeal, Hagemeister, Fredrick B., Romaguera, Jorge, Preti, Alejandro, Bachier, Carlos, Cabanillas, Fernando

    Published in Leukemia & lymphoma
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: